ArticleFrontiers in oncology2021

The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine.

Yanli Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.